CRIOKEEP: device for the cryogenic storage, transport and dosing of therapeutic products
Project fact sheet
CRIOKEEP
Vertical: Customised health
Project description
The effectiveness and cost of using advanced therapeutic products is currently limited by the need to use different consumables to comply with the protocols (storage, transport and dosage for the patient).
CRIOKEEP proposes a solution that includes in a single consumable devices the functions of cryogenic storage, transport and dosing of a therapeutic product to the patient, while reducing the number of processes. The risks of contamination, sample loss and loss of traceability with the counter-sample are thus eliminated…
The project – focused on its use in advanced therapies of customised medicine (cellular, gene….) – is based on a product that has been developed, tested and patented by Leartiker in collaboration with CUN, with the ensuing competitive advantage.
Tagline: Device for the cryogenic storage, transport and dosing of therapeutic products.
Financing needs:
CEO contracting: €65,000 a year
Manufacturing process development: €45,000 (excluding Leartiker support)
Certification costs (CE marking): €120,000 (excluding Leartiker and CUN support)
Costs of deploying commercial/productive action plan: €22,000 (excluding Leartiker support)
Costs of the stage of increasing product range (mould): €23,000 (excluding Leartiker support).
Market
Phase 1: Cellular therapy and regenerative medicine units (Hospitals)
Phase 2: Medical distributors
Technology tags
Business model
Project needs
Promoted by
Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news
Prospect Biotech: real-time analysis of cell cultures using light
Basque Tek Ventures is backing this project that offers an optic solution to develop and monitor advanced therapies.
Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.
Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.
K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.
INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.
FATRIXGEL: universal biomaterial for 3D cell cultures
The project, coming under Basque Tek Ventures, will revolutionise the generation of tissues to be used to research pharmaceutical and biotechnological therapies.
BATTBELT: mechanical management of batteries to improve their performance
The project, which is part of the Basque Tek Ventures initiative, helps to extend the life and energy density of lithium-ion batteries.
ORBIK: cybersecurity solutions for equipment with embedded electronics
Certification of technology products by means of assessing, detecting and monitoring their security vulnerabilities is the basis of this project hosted by the Basque Tek Ventures initiative.
OPTIDEL Biosystems: low liquefiable polyphenol solubilisation
The project, backed by the Basque Tek Ventures initiative, offers cosmetic-healthcare solutions to formulate more efficient topical products at a low cost.
NEWRO: stroke neurorehabilitation using robotic exoskeleton
The project, part of the Basque Tek Ventures initiative, will lead to therapies based on the hybrid brain-machine interface to recover after any degree of stroke.